Temas de actualidad en insuficiencia cardiaca

Revista Española de Cardiología Suplementos - Tập 9 - Trang 92-100 - 2009
Josep Comín Colet1, Roberto Muñoz Aguilera2, José J. Cuenca Castillo3, Juan F. Delgado Jiménez4
1Programa de Insuficiencia Cardiaca. Servicio de Cardiología. Hospital del Mar (IMAS). Barcelona. España
2Servicio de Cardiología. Hospital Infanta Leonor. Madrid. España
3Servicio de Cirugía Cardiaca. Complejo Hospitalario Juan Canalejo. A Coruña. España
4Servicio de Cardiología, Hospital Universitario 12 de Octubre, Madrid, España

Tài liệu tham khảo

Jaarsma, 2008, Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH), Arch Intern Med, 168, 316, 10.1001/archinternmed.2007.83 Chaudhry, 2007, Telemonitoring for patients with chronic heart failure: a systematic review, J Card Fail, 13, 56, 10.1016/j.cardfail.2006.09.001 Clark, 2007, Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis, BMJ, 334, 942, 10.1136/bmj.39156.536968.55 Fonarow, 2007, Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF, J Card Fail, 13, 722, 10.1016/j.cardfail.2007.06.727 Fonarow, 2008, Influence of betablocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZEHF program, J Am Coll Cardiol, 52, 190, 10.1016/j.jacc.2008.03.048 Tousoulis, 2008, Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression, J Card Fail, 14, 456, 10.1016/j.cardfail.2008.02.015 Ghali, 2008, Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia, Circulation, 117, 526, 10.1161/CIRCULATIONAHA.107.698514 Ponikowski, 2007, Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure —a randomized, double-blind, placebo-controlled trial, J Am Coll Cardiol, 49, 753, 10.1016/j.jacc.2006.11.024 Van Veldhuisen, 2007, Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia, Eur Heart J, 28, 2208, 10.1093/eurheartj/ehm328 Mancini, 2003, Effect of erythropoietin on exercise capacity in anemic patients with advanced heart failure, Kidney Int, 64, S48, 10.1046/j.1523-1755.64.s87.8.x Silverberg, 2001, The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study, J Am Coll Cardiol, 37, 1775, 10.1016/S0735-1097(01)01248-7 Okonko, 2008, Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency, J Am Coll Cardiol, 51, 103, 10.1016/j.jacc.2007.09.036 Toblli, 2007, Intravenous iron reduces NT-Pro-Brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency, J Am Coll Cardiol, 50, 1657, 10.1016/j.jacc.2007.07.029 Bolger, 2006, Intravenous iron alone for the treatment of anemia in patients with chronic heart failure, J Am Coll Cardiol, 48, 1225, 10.1016/j.jacc.2006.07.015 Kjekshus, 2007, Rosuvastatin in older patients with systolic heart failure, N Engl J Med, 357, 2248, 10.1056/NEJMoa0706201 Ramasubbu, 2008, Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy, J Am Coll Cardiol, 51, 415, 10.1016/j.jacc.2007.10.009 Tavazzi, 2004, Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure, Eur J Heart Fail, 6, 635, 10.1016/j.ejheart.2004.03.001 Guazzi, 2007, Long-term use of sildenafil in the therapeutic management of heart failure, J Am Coll Cardiol, 50, 2136, 10.1016/j.jacc.2007.07.078 Lewis, 2007, Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension, Circulation, 116, 1555, 10.1161/CIRCULATIONAHA.107.716373 Goldsmith, 2007, Type 5 phosphodiesterase inhibition in heart failure: the next step, J Am Coll Cardiol, 50, 2145, 10.1016/j.jacc.2007.07.075 Hare, 2008, Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study, J Am Coll Cardiol, 51, 2301, 10.1016/j.jacc.2008.01.068 Chung, 2008, Results of the Predictors of Response to CRT (PROSPECT) trial, Circulation, 117, 2608, 10.1161/CIRCULATIONAHA.107.743120 Beshai, 2007, Cardiac-resynchronization therapy in heart failure with narrow QRS complexes, N Engl J Med, 357, 2461, 10.1056/NEJMoa0706695 Fang, 2008, Heart failure-related hospitalization in the U.S., 1979 to 2004, J Am Coll Cardiol, 52, 428, 10.1016/j.jacc.2008.03.061 Nieminen, 2005, Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca aguda. Versión resumida, Rev Esp Cardiol, 58, 389, 10.1157/13073896 Cotter, 2008, The pathophysiology of acute heart failure —is it all about fluid accumulation?, Am Heart J, 155, 9, 10.1016/j.ahj.2006.02.038 Metra, 2008, The pathophysiology of acute heart failure —it is a lot about fluid accumulation, Am Heart J, 155, 1, 10.1016/j.ahj.2007.10.011 Nohria, 2008, Cardiorenal interactions: insights from the ESCAPE trial, J Am Coll Cardiol, 51, 1268, 10.1016/j.jacc.2007.08.072 Braunwald, 2008, Biomarkers in heart failure, N Engl J Med, 358, 2148, 10.1056/NEJMra0800239 Waldo, 2008, Pro-B-type natriuretic peptide levels in acute decompensated heart failure, J Am Coll Cardiol, 51, 1874, 10.1016/j.jacc.2007.12.051 Peacock, 2008, Cardiac troponin and outcome in acute heart failure, N Engl J Med, 358, 2117, 10.1056/NEJMoa0706824 Mullens, 2008, Sodium nitroprusside for advanced low-output heart failure, J Am Coll Cardiol, 52, 200, 10.1016/j.jacc.2008.02.083 Yancy, 2008, Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: Results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) Trial, Circ Heart Fail, 1, 9, 10.1161/CIRCHEARTFAILURE.108.767483 Gheorghiade, 2007, Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials, JAMA, 297, 1332, 10.1001/jama.297.12.1332 Givertz, 2007, The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance, J Am Coll Cardiol, 50, 1551, 10.1016/j.jacc.2007.07.019 Cleland, 2008, Clinical trials update from the American College of Cardiology 2008: CARISMA, TRENDS, meta-analysis of Cox-2 studies, HAT, ON-TARGET, HYVET, ACCOMPLISH, MOMENTUM, PROTECT, HORIZONHF and REVERSE, Eur J Heart Fail, 10, 614, 10.1016/j.ejheart.2008.05.003 Mebazaa, 2007, Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial, JAMA, 297, 1883, 10.1001/jama.297.17.1883 Gheorghiade, 2008, Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure, J Am Coll Cardiol, 51, 2276, 10.1016/j.jacc.2008.03.015 Gray, 2008, Noninvasive ventilation in acute cardiogenic pulmonary edema, N Engl J Med, 359, 142, 10.1056/NEJMoa0707992 Costanzo, 2007, Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure, J Am Coll Cardiol, 49, 675, 10.1016/j.jacc.2006.07.073 Cuenca, 2006, Tratamiento quirúrgico de la insuficiencia cardiaca. Restauración ventricular y cirugía de la válvula mitral, Rev Esp Cardiol Supl, 6, F71, 10.1157/13091627 Blom, 2007, The surgical treatment of end-stage heart failure, Curr Probl Cardiol, 32, 553, 10.1016/j.cpcardiol.2007.08.001 Acker, 2006, Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial, J Thorac Cardiovasc Surg, 132, 568, 10.1016/j.jtcvs.2006.02.062 Mann, 2007, Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy, Ann Thorac Surg, 84, 1226, 10.1016/j.athoracsur.2007.03.095 Starling, 2007, Sustained benefits of the CorCap Cardiac Support Device on left ventricular remodeling: three year followup results from the Acorn clinical trial, Ann Thorac Surg, 84, 1236, 10.1016/j.athoracsur.2007.03.096 Rose, 2001, Long-term mechanical left ventricular assistance for end-stage heart failure, N Engl J Med, 345, 1435, 10.1056/NEJMoa012175 Rogers, 2007, Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial, J Am Coll Cardiol, 50, 741, 10.1016/j.jacc.2007.03.063 Kirklin, 2006, Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances), Curr Opin Cardiol, 21, 120, 10.1097/01.hco.0000210308.64360.8d Garatti, 2008, Clinical outcome and bridge to transplant rate of left ventricular assist device recipient patients: comparison between continuous-flow and pulsatile-flow devices, Eur J Cardiothorac Surg, 34, 275, 10.1016/j.ejcts.2008.02.019 Delgado, 2008, Avances en asistencias circulatorias mecánicas, Rev Esp Cardiol, 61, 25